title: Another adverse effect of vemurafenib: Gingival hyperplasia.
authors.affiliation: Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Andac
authors.initials: A
authors.lastname: Salman
authors.affiliation: Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Burak
authors.initials: B
authors.lastname: Tekin
authors.affiliation: Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Sinan
authors.initials: S
authors.lastname: Koca
authors.affiliation: Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Nalan
authors.initials: N
authors.lastname: Akgul Babacan
authors.affiliation: Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Perran Fulden
authors.initials: PF
authors.lastname: Yumuk
authors.affiliation: Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Tulin
authors.initials: T
authors.lastname: Ergun
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005885:Gingival Hyperplasia / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib